Goldman Sachs Group Inc Biomerica Inc Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Biomerica Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 40,892 shares of BMRA stock, worth $15,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,892Holding current value
$15,130% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMRA
# of Institutions
36Shares Held
2.38MCall Options Held
0Put Options Held
0-
Granahan Investment Management, LLC Waltham, MA860KShares$318,3680.02% of portfolio
-
Russell Investments Group, Ltd.226KShares$83,6640.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA215KShares$79,4220.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$62,0490.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$55,1590.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $4.97M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...